New Validation and Clinical Outcome Data From Several Studies Using Nanosphere's Infectious Disease Tests to be Presented at ECCMID 2014
May 8, 2014 | Nanosphere News
Nanosphere today announced that new validation and clinical outcome data for select Verigene® multiplex molecular infectious disease tests will be presented at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) to be held in Barcelona, Spain on 10 – 13 May 2014.